(Fri-27-01-2017, 12:39 PM)Bill Wrote: Yes, fine now Jim, although I will probably check it in a week or two and make sure the tensioner is still set correctly. Personally I think that Biogen should be forking out for the MRI scans. The data collected will give a better determination of the safety of DMF, so it just looks like free research being done for Biogen.
Cheers,
Bill
I agree Bill they produce a drug. Charge a high price for it and health services around the world pick up the monitoring bill..... but poor cash strapped Biogen can't afford that
I was just reading that their projected turnover for the MS. Drug will be over 4 billion for this one drug, for this year alone ..... not bad when the raw product is extremely cheap